1. Mundy, G.R., Raisz, L.G., Cooper, R.A. et al. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 1974, 291, 1041–1046.
2. Bataille, R., Chappard, D., Marcelli, C., Dessauw, P., Sany, J., Baldet, P., Alexandre, C. Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol 1989, 7, 1909–1914.
3. Bataille, R., Chappard, D., Klein, B. Mechanisms of bone lesions in multiple myeloma. Hematol Oncol 1992, 6, 285–295.
4. Laroche, M., Cantagrel, A., Degraeve, J., Mazieres, B., Arlet, J. Avantages et inconvenients de l'étude de l'excrétion urinaire à jeun du calcium et du phosphore comparée aux dosages de 24 heures. Sem Hop Paris, 1988, 64, 81–84.
5. Nordin, B.E.C. Diagnosis procedures in disorders of calcium metabolism. Clin Endocrinol, 1978, 8, 56–67.